Sun Pharmaceutical Industries Limited at its board meeting held on May 26, 2023, recommended final dividend of INR 4.00 per equity share of INR l each of the Company for financial year 2022-2023, subject To Approve the shareholders at the upcoming 31st Annual General Meeting and which shall be paid within the timelines as required under the Companies Act, 2013.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,525 INR | +0.92% | +0.21% | +21.07% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.07% | 43.48B | |
+20.67% | 22.65B | |
+12.97% | 14.73B | |
+14.09% | 13.79B | |
+46.33% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited Recommends Final Dividend for Financial Year 2022-2023